July/August
Global Biopharma Launches in the New World Order
Biopharma blockbusters in the last 10 years show a disturbing trend. On average, they ...
Adherence to Treatment: Making the Most of the First 30 Days
Medication non-adherence has a staggering impact on the industry’s ability to serve patient well-being ...
Old School or New School—Marketing Inspiration Can Come From Any Direction
The important (and fun!) thing about marketing pharmaceutical products is not grand strategies or ...
PM360 Q&A with Adrian Adams, Chairman & CEO, Impel Pharmaceuticals
Over the course of his career, Adrian Adams has served as CEO of seven ...
Readjusting the Life Sciences Industry’s Approach to Improving Adherence
Addressing the issue of medication adherence begins before a patient even fills their first ...
Two Key Questions About Adherence/Compliance in 2022
PM360 asked life sciences industry experts with knowledge about improving adherence to medication to ...
10 New Solutions, Strategies, and Devices to Boost Adherence
How can we help ensure patients continue to take their medications as prescribed? Doctors, ...
Adjusting to a World Without Blockbusters
The era of the global pharmaceutical blockbuster is coming to an end. According to ...
Fewer Prescribers Are Driving NBRx Than You Think—Here’s Why
According to a 2021 study by Statista, 40% of prescriptions written in 2005 were ...
Healthcare Watch July/August 2022
Brand Beat: Juul Fights FDA Ban Shortly after banning Juul from selling its products, ...
Industry Briefs July/August 2022
Pfizer Takes Novel Approach to Helping Ukraine Unlike other corporations that have implemented sanctions ...
3 Key Factors Driving Patient Adherence and Compliance
The statistics relating to patients’ adherence to their prescribed medication regimes continue to be ...
Assessing Medical Affairs Organizational Capabilities
As part of our series covering the future of Medical Affairs, we discussed how ...
